3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
49
Lymphoma, Large B-Cell, Diffuse
17
Lymphoma, Follicular
14
Lymphoma, B-Cell, Marginal Zone
13
Lymphoma
9
Recurrence
7
Lymphoma, Non-Hodgkin
7
Neoplasms
6
Lymphoma, Mantle-Cell
5
Lymphoma, B-Cell
4
Neoplasms, Plasma Cell
3
Neoplasm, Residual
3
Lymphoma, T-Cell, Peripheral
3
Smoldering Multiple Myeloma
2
Leukemia, Plasma Cell
2
Hematologic Neoplasms
2
Burkitt Lymphoma
2
Waldenstrom Macroglobulinemia
1
Vitamin D Deficiency
1
Peripheral Nervous System Diseases
1
Paraproteinemias
1
Leukemia, Myeloid, Acute
1
Leukemia, Hairy Cell
1
Hodgkin Disease
1
Hematologic Diseases
1
Heart Failure
1
Dendritic Cell Sarcoma, Interdigitating
1
Corneal Diseases
1
Cardiotoxicity
1
Blood Protein Disorders
1
Interventions
pembrolizumab
1
enfortumab vedotin
1
Thioctic Acid
1
Tablets
1
Music Therapy
1
Lenalidomide
1
Gloves, Surgical
1
Fish Oils
1
Fenofibrate
1
Exercise
1
Dexamethasone
1
Cryotherapy
1
Corn Oil
1
Bortezomib
1
Acupuncture Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Peripheral Nervous System Diseases
×
Lenalidomide
×
Clear all
NCT07025005
2025-11-04
VRd MM Fibrate
Tanta University
Phase 4
Recruiting
44 enrolled